Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
9.71
+0.15 (1.57%)
At close: Aug 13, 2025, 4:00 PM
9.67
0.00 (0.00%)
Pre-market: Aug 14, 2025, 8:59 AM EDT
Exagen Employees
As of December 31, 2024, Exagen had 215 total employees, including 209 full-time and 6 part-time employees. The number of employees increased by 36 or 20.11% compared to the previous year.
Employees
215
Change (1Y)
36
Growth (1Y)
20.11%
Revenue / Employee
$273,777
Profits / Employee
-$78,977
Market Cap
213.66M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
XGN News
- 7 days ago - Exagen Inc. to Participate in Third Quarter Investor Conferences - GlobeNewsWire
- 15 days ago - Exagen Inc. (XGN) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 16 days ago - Exagen Inc. Reports Strong Q2 2025 Results - GlobeNewsWire
- 27 days ago - Exagen Inc. Appoints Chas McKhann to Board of Directors - GlobeNewsWire
- 4 weeks ago - Exagen Inc. to Announce Second Quarter 2025 Financial Results on July 29, 2025 - GlobeNewsWire
- 7 weeks ago - Michael Mahler, PhD Joins Exagen as Chief Scientific Officer to Enhance Leadership in Autoimmune Diagnostics - GlobeNewsWire
- 3 months ago - Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of Underwriter's Option to Purchase Additional Shares - GlobeNewsWire
- 3 months ago - Exagen Inc. Prices Public Offering of Common Stock - GlobeNewsWire